Total Payments
$32,580
2023 Payments
$1,200
Companies
7
Transactions
37
Medicare Patients
1,658
Medicare Billing
$124,707
Payment Breakdown by Category
Research$20,000 (61.4%)
Other$5,429 (16.7%)
Travel$3,850 (11.8%)
Food & Beverage$1,905 (5.8%)
Consulting$1,397 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $20,000 | 1 | 61.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,000 | 2 | 15.3% |
| Travel and Lodging | $3,850 | 14 | 11.8% |
| Food and Beverage | $1,905 | 17 | 5.8% |
| Consulting Fee | $1,397 | 2 | 4.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $428.60 | 1 | 1.3% |
Payments by Type
Research
$20,000
1 transactions
General
$12,580
36 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bracco Diagnostics Inc. | $29,188 | 26 | $0 (2023) |
| Lantheus Medical Imaging, Inc. | $3,088 | 2 | $0 (2017) |
| Edwards Lifesciences Corporation | $154.16 | 1 | $0 (2022) |
| Boston Scientific Corporation | $70.08 | 3 | $0 (2020) |
| Abbott Laboratories | $35.10 | 2 | $0 (2017) |
| Medtronic Vascular, Inc. | $28.42 | 2 | $0 (2020) |
| Amgen Inc. | $16.47 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,200 | 1 | Bracco Diagnostics Inc. ($1,200) |
| 2022 | $154.16 | 1 | Edwards Lifesciences Corporation ($154.16) |
| 2020 | $28.25 | 2 | Boston Scientific Corporation ($15.00) |
| 2019 | $428.60 | 1 | BRACCO DIAGNOSTICS INC. ($428.60) |
| 2018 | $26,163 | 21 | BRACCO DIAGNOSTICS INC. ($26,132) |
| 2017 | $4,606 | 11 | Lantheus Medical Imaging, Inc. ($3,088) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2023 | Bracco Diagnostics Inc. | Lumason (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Diagnostic Imaging | ||||||
| 01/31/2022 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $154.16 | General |
| 10/09/2020 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 02/28/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: STRUCTURAL HEART | ||||||
| 01/08/2019 | BRACCO DIAGNOSTICS INC. | CEUS (Drug) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $428.60 | General |
| Category: CONTRAST MEDIA | ||||||
| 10/05/2018 | BRACCO DIAGNOSTICS INC. | CEUS (Drug) | Food and Beverage | Cash or cash equivalent | $59.68 | General |
| Category: CONTRAST MEDIA | ||||||
| 08/28/2018 | BRACCO DIAGNOSTICS INC. | CEUS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: CONTRAST MEDIA | ||||||
| 05/01/2018 | BRACCO DIAGNOSTICS INC. | LUMASON (Drug) | — | Cash or cash equivalent | $20,000.00 | Research |
| Study: A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis of Coronary Artery Disease • Category: CONTRAST MEDIA | ||||||
| 03/27/2018 | BRACCO DIAGNOSTICS INC. | SonoVue (Drug) | Travel and Lodging | Cash or cash equivalent | $270.90 | General |
| Category: CONTRAST MEDIA | ||||||
| 03/27/2018 | BRACCO DIAGNOSTICS INC. | SonoVue (Drug) | Food and Beverage | Cash or cash equivalent | $143.73 | General |
| Category: CONTRAST MEDIA | ||||||
| 03/16/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardiology | ||||||
| 02/26/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $143.35 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/26/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $135.15 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/26/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $119.90 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/19/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $145.15 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/19/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $139.35 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/13/2018 | BRACCO DIAGNOSTICS INC. | SonoVue (Drug) | Food and Beverage | Cash or cash equivalent | $78.00 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/13/2018 | BRACCO DIAGNOSTICS INC. | SonoVue (Drug) | Travel and Lodging | Cash or cash equivalent | $63.00 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/05/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $716.00 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/05/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $145.35 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/05/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $135.15 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/05/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $119.90 | General |
| Category: CONTRAST MEDIA | ||||||
| 02/05/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $119.90 | General |
| Category: CONTRAST MEDIA | ||||||
| 01/31/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $782.00 | General |
| Category: CONTRAST MEDIA | ||||||
| 01/26/2018 | BRACCO DIAGNOSTICS INC. | SONOVUE (Drug) | Travel and Lodging | Cash or cash equivalent | $815.00 | General |
| Category: CONTRAST MEDIA | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis of Coronary Artery Disease | BRACCO DIAGNOSTICS INC. | $20,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 456 | 524 | $175,441 | $39,341 |
| 2022 | 12 | 529 | 640 | $170,399 | $48,864 |
| 2021 | 10 | 348 | 356 | $82,088 | $21,642 |
| 2020 | 6 | 325 | 331 | $54,736 | $14,861 |
Total Patients
1,658
Total Services
1,851
Medicare Billing
$124,707
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 117 | 137 | $60,557 | $15,643 | 25.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 59 | 59 | $31,336 | $8,107 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 53 | $17,350 | $4,031 | 23.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 46 | 47 | $8,085 | $2,560 | 31.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 30 | 69 | $5,639 | $1,759 | 31.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $5,288 | $1,695 | 32.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 18 | 18 | $4,798 | $1,562 | 32.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 15 | 15 | $34,811 | $1,511 | 4.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 20 | $3,819 | $1,291 | 33.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 32 | 32 | $2,016 | $649.60 | 32.2% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Facility | 2023 | 15 | 15 | $1,278 | $386.69 | 30.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 31 | 31 | $248.00 | $75.90 | 30.6% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 12 | 12 | $216.00 | $69.60 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 143 | 194 | $79,683 | $21,881 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 65 | 65 | $31,984 | $8,893 | 27.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 76 | 77 | $13,364 | $4,420 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 52 | $15,582 | $4,042 | 25.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $6,002 | $1,967 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 34 | $5,984 | $1,964 | 32.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 34 | 75 | $6,087 | $1,907 | 31.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 20 | 20 | $5,340 | $1,778 | 33.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,721 | $810.70 | 29.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 36 | 36 | $2,268 | $747.09 | 32.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 20 | 20 | $1,080 | $356.36 | 33.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 38 | 38 | $304.00 | $98.49 | 32.4% |
About Dr. Kevin Wei, MD
Dr. Kevin Wei, MD is a Cardiovascular Disease healthcare provider based in The Dalles, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962418574.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Wei, MD has received a total of $32,580 in payments from pharmaceutical and medical device companies, with $1,200 received in 2023. These payments were reported across 37 transactions from 7 companies. The most common payment nature is "" ($20,000).
As a Medicare-enrolled provider, Wei has provided services to 1,658 Medicare beneficiaries, totaling 1,851 services with total Medicare billing of $124,707. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location The Dalles, OR
- Active Since 08/01/2006
- Last Updated 11/02/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1962418574
Products in Payments
- LUMASON (Drug) $20,000
- SONOVUE (Drug) $3,516
- Definity (Drug) $3,088
- CEUS (Drug) $2,488
- ISOVUE (Drug) $1,428
- Lumason (Drug) $1,200
- SonoVue (Drug) $555.63
- EMBLEM (Device) $42.30
- Connectivity and Remote care (Device) $22.29
- Repatha (Biological) $16.47
- Azure (Device) $15.17
- WATCHMAN (Device) $15.00
- Reveal LINQ (Device) $13.25
- Mitra Clip system (Device) $12.81
- IMAGEREADY MR-CONDITIONAL PACING SYSTEM (Device) $12.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.